Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | China | 28 Feb 2024 | |
Nonalcoholic Steatohepatitis | Phase 1 | Australia | 01 Aug 2022 | |
Primary Biliary Cholangitis | Phase 1 | China | - |